ARK Invest Sells $35 Million UiPath Stake Despite 17% Revenue Growth
Fazen Markets Editorial Desk
Collective editorial team · methodology
Fazen Markets Editorial Desk
Collective editorial team · methodology
Trades XAUUSD 24/5 on autopilot. Verified Myfxbook performance. Free forever.
Risk warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. The majority of retail investor accounts lose money when trading CFDs. Vortex HFT is informational software — not investment advice. Past performance does not guarantee future results.
ARK Investment Management, the growth-focused asset manager founded by Cathie Wood, liquidated a $35 million position in UiPath Inc. during Q1 2026. The sale was disclosed in regulatory filings analyzed by finance.yahoo.com. UiPath, a leader in robotic process automation (RPA) software, reported a 17% year-over-year revenue increase for its most recent quarter alongside the divestment. The transaction reduces ARK's exposure to one of its longstanding automation holdings.
ARK's last major reduction in a core automation holding occurred in late 2024, when it trimmed its stake in Trimble Inc. by approximately $50 million. The current macro backdrop features a lower interest rate environment than the previous decade, with the 10-year Treasury yield at 4.15%. This should theoretically support valuations for long-duration growth stocks like UiPath.
What changed is a strategic re-assessment of total addressable market saturation within enterprise RPA. Major cloud providers like Microsoft and Amazon have aggressively embedded automation tools directly into their core platforms. This encroachment has compressed the standalone market opportunity for pure-play RPA vendors. The trigger for the sale now, despite solid revenue growth, is a revised forecast for UiPath's long-term market share and pricing power.
UiPath reported Q1 2026 revenue of $335.2 million, a 17% increase from $286.5 million in the year-ago quarter. The company's annual recurring revenue (ARR) reached $1.34 billion. Despite this growth, its stock price declined 22% over the six months preceding ARK's sale, underperforming the Nasdaq Composite's 3% gain over the same period.
ARK's sale involved approximately 1.2 million shares at an average price near $29. This reduced the fund's total UiPath holdings by roughly 40%. The transaction leaves ARK with an estimated 1.8 million shares, valued at approximately $52 million post-sale.
UiPath's forward price-to-sales ratio contracted to 6.2 from over 10 a year prior. Peers like Appian and Pegasystems trade at forward P/S ratios of 4.8 and 3.5, respectively, indicating a sector-wide de-rating. The company holds $1.85 billion in cash and equivalents against no long-term debt.
The divestment signals institutional skepticism about the premium valuation of standalone automation software. Second-order beneficiaries are likely the dominant cloud platforms integrating these tools. Microsoft, with its Power Automate suite embedded in Office 365 and Azure, could capture market share. ServiceNow, which offers workflow automation within its IT service management platform, may also see increased investor interest.
A key limitation to this analysis is that ARK's sale may be portfolio-specific rather than a broad condemnation of UiPath's business. The fund frequently rebalances to concentrate capital into its highest-conviction ideas, which currently center on artificial intelligence and genomic sequencing. The counter-argument is that UiPath's 17% growth, while decelerating, remains strong for a company of its scale.
Positioning data shows hedge funds have been net sellers of RPA stocks for three consecutive quarters. Institutional flow is rotating toward companies building foundational AI models or providing AI infrastructure, such as Nvidia and certain semiconductor equipment makers.
UiPath's next earnings report, scheduled for 24 July 2026, will be scrutinized for guidance on net new ARR and customer expansion rates. Investors will monitor whether growth stabilizes above 15% or decelerates further into the low teens. The key level for PATH stock is the $25 support zone, a level not tested since late 2025. A breach could signal a deeper re-rating.
The next major catalyst for the automation software sector is Microsoft's Build developer conference in late June. Any announcement expanding Power Automate's capabilities or integration could pressure pure-play RPA vendors. For ARK, watch its next monthly transaction disclosure for continued trimming in mature software holdings versus new accumulation in early-stage AI companies.
Retail investors should not interpret a single fund's sale as an immediate sell signal. ARK manages concentrated, high-conviction portfolios that require frequent rebalancing. The action highlights the importance of monitoring total addressable market assumptions for any growth stock. Retail holders should focus on UiPath's own fundamentals, particularly its ability to maintain double-digit revenue growth and expand its platform beyond core RPA into broader AI-driven automation.
ARK's 2021 sale of Tesla shares was a partial profit-taking move after a historic rally, reducing a position that had grown to over 10% of some funds. The UiPath sale is different; it is a strategic reduction in a holding that has underperformed the fund's benchmark. The 2021 Tesla sale occurred during rising momentum, while the UiPath sale follows six months of price decline, indicating a reassessment of the investment thesis rather than simple portfolio management.
Automation software companies, including UiPath, traded at premium valuations during the peak of digital transformation spending from 2020 to 2022. Forward price-to-sales ratios often exceeded 25 for high-growth leaders. The current sector de-rating mirrors the broader compression in SaaS valuations post-2022 as interest rates rose and growth normalized. The current P/S range of 3 to 6 reflects a market pricing these firms as mature software vendors, not hyper-growth disruptors.
ARK's sale reflects a strategic shift away from maturing automation software toward earlier-stage technological disruptions.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.
Vortex HFT is our free MT4/MT5 Expert Advisor. Verified Myfxbook performance. No subscription. No fees. Trades 24/5.
Trade 800+ global stocks & ETFs
Start TradingSponsored
Open a demo account in 30 seconds. No deposit required.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.